news https://www.globenewswire.com/news-release/2022/08/19/2501588/0/en/Todos-Medical-Announces-Preprint-of-Data-from-First-100-Participants-in-IRB-waived-Market-Research-Study-of-Supplementation-with-Tollovid-in-Long-COVID.html